Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
    12.
    发明授权
    Antimicrobial quinolone derivatives and use of the same to treat bacterial infections 失效
    抗菌喹诺酮衍生物及其用途,用于治疗细菌感染

    公开(公告)号:US06689769B2

    公开(公告)日:2004-02-10

    申请号:US09996927

    申请日:2001-11-29

    IPC分类号: A61K3133

    摘要: Substituted quinolone derivatives in which an oxazolidinone, isoxazolinone, or isoxazoline is covalently bonded to a quinolone, methods of using the quinolone derivatives, and pharmaceutical compositions containing the quinolone derivatives are disclosed. Methods of synthesizing these substituted quinolone derivatives are also disclosed, and in particular a method of manufacturing a 7-(2-oxo-1,3-oxazolidin-3-yl)aryl-3-quinolinecarboxylic acid by condensing a 4-(2-oxo-1,3-oxazolidin-5-yl)aryl boronic acid with a 7-halo-quinolone derivative. The quinolone derivatives possess antibacterial activity, and are effective against a number of human and veterinary pathogens in the treatment of bacterial diseases.

    摘要翻译: 公开了其中恶唑烷酮,异恶唑啉酮或异恶唑啉与喹诺酮共价键合的取代喹诺酮衍生物,使用喹诺酮衍生物的方法和含喹诺酮衍生物的药物组合物。 还公开了合成这些取代的喹诺酮衍生物的方法,特别是7-(2-氧代-1,3-恶唑烷-3-基)芳基-3-喹啉羧酸的制备方法, 氧代-1,3-恶唑烷-5-基)芳基硼酸与7-卤代喹诺酮衍生物反应。 喹诺酮衍生物具有抗菌活性,在治疗细菌性疾病方面对许多人和兽医病原体有效。

    Solid phase and combinatorial library syntheses of fused 2,4-pyrimidinediones
    13.
    发明授权
    Solid phase and combinatorial library syntheses of fused 2,4-pyrimidinediones 失效
    稠合的2,4-嘧啶二酮的固相和组合文库合成

    公开(公告)号:US06413724B1

    公开(公告)日:2002-07-02

    申请号:US08795189

    申请日:1997-02-04

    IPC分类号: G01N3353

    摘要: The invention provides chemistry libraries containing fused 2,4-pyrimidinediones. The invention also provides methods for the construction of fused 2,4-pyrimidinedione containing libraries. The invention further provides methods for the identification of bioactive, fused 2,4-pyrimidinediones from those libraries.

    摘要翻译: 本发明提供了含有稠合的2,4-嘧啶二酮的化学文库。 本发明还提供了构建稠合的含有2,4-嘧啶二酮的文库的方法。 本发明还提供从这些文库鉴定生物活性的稠合的2,4-嘧啶酮的方法。

    Kinase Inhibitors
    20.
    发明申请
    Kinase Inhibitors 有权
    激酶抑制剂

    公开(公告)号:US20080200485A1

    公开(公告)日:2008-08-21

    申请号:US11667205

    申请日:2005-11-17

    摘要: Disclosed are protein kinase inhibitors, compositions comprising such inhibitors, and methods of use, thereof. More particularly, disclosed are inhibitors of Aurora-2 (Aurora-A) protein kinase. Also disclosed are methods of treating diseases associated with protein kinases, especially diseases associated with Aurora-2, such as cancer.

    摘要翻译: 公开了蛋白激酶抑制剂,包含这种抑制剂的组合物及其使用方法。 更具体地,公开了Aurora-2(Aurora-A)蛋白激酶的抑制剂。 还公开了治疗与蛋白激酶相关疾病的方法,特别是与Aurora-2相关的疾病,例如癌症。